Company Organon & Co.

Company Organon & Co.

OGN

US68622V1061

Pharmaceuticals

Analysts' Consensus

Equities

OGN

US68622V1061

Pharmaceuticals

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Ratings for Organon & Co.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Ratings for Organon & Co.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2024-05-31 pm EDT			5-day change	1st Jan Change
21.33 ^USD	+1.86%		+1.62%	+47.92%

May. 24	Organon, Henlius' Denosumab Biosimilar HLX14 Gets European Validation	MT
May. 24	Shanghai Henlius Biotech, Inc. and Organon Announces That the European Medicines Agency Has Validated the Marketing Authorization Applications for Hlx14	CI

Organon & Co. is a global health care company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and established brands. It has a portfolio of contraception and fertility brands, including Nexplanon, NuvaRing, and Follistim AQ. The Companyâs Biosimilars portfolio spans across immunology and oncology treatments. It also has a portfolio of established brands, including brands in cardiovascular, respiratory, dermatology and non-opioid pain management. It sells these products through various channels, including drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. The Company operates six manufacturing facilities, which are located in Belgium, Brazil, Indonesia, Mexico, the Netherlands and the United Kingdom.

Number of employees: 10,000

USD in Million	2022	Weight	2023	Weight	Delta
Women's Health - Nexplanon/Implanon NXT 13.3 %	834	13.5 %	830	13.3 %	-0.48%
Cardiovascular - Atozet 8.3 %	457	7.4 %	519	8.3 %	+13.57%
Respiratory - Singulair 6.5 %	411	6.7 %	404	6.5 %	-1.70%
Other - Other 5.1 %	326	5.3 %	319	5.1 %	-2.15%
Cardiovascular - Zetia 4.9 %	357	5.8 %	306	4.9 %	-14.29%
Cardiovascular - Cozaar/Hyzaar 4.5 %	323	5.2 %	281	4.5 %	-13.00%
Biosimilars - Renflexis 4.4 %	226	3.7 %	278	4.4 %	+23.01%
Other Non-opioid Pain, Bone and Dermatology 4.4 %	273	4.4 %	275	4.4 %	+0.73%
Women's Health - Follistim AQ 4.2 %	229	3.7 %	262	4.2 %	+14.41%
Non-opioid Pain, Bone and Dermatology - Arcoxia 4.1 %	241	3.9 %	257	4.1 %	+6.64%
Respiratory - Nasonex 4.0 %	238	3.9 %	253	4.0 %	+6.30%
Respiratory - Dulera 3.1 %	180	2.9 %	194	3.1 %	+7.78%
Other Women's Health 2.7 %	204	3.3 %	171	2.7 %	-16.18%
Non-opioid Pain, Bone and Dermatology - Fosamax 2.5 %	152	2.5 %	159	2.5 %	+4.61%
Biosimilars - Ontruzant 2.5 %	122	2.0 %	155	2.5 %	+27.05%
Other Cardiovascular 2.5 %	159	2.6 %	155	2.5 %	-2.52%
Women's Health - NuvaRing 2.4 %	173	2.8 %	152	2.4 %	-12.14%
Respiratory - Clarinex 2.2 %	125	2.0 %	136	2.2 %	+8.80%
Women's Health - Marvelon/Mercilon 2.1 %	110	1.8 %	134	2.1 %	+21.82%
Cardiovascular - Vytorin 2.1 %	130	2.1 %	129	2.1 %	-0.77%
Other - Propecia 2.0 %	125	2.0 %	125	2.0 %	-.--%
Other 1.9 %	146	2.4 %	121	1.9 %	-17.12%
Women's Health - Ganirelix Acetate Injection 1.8 %	123	2.0 %	110	1.8 %	-10.57%
Other - Proscar 1.5 %	101	1.6 %	97	1.5 %	-3.96%
Non-opioid Pain, Bone and Dermatology - Diprospan 1.5 %	122	2.0 %	91	1.5 %	-25.41%
Other Respiratory 1.2 %	83	1.3 %	77	1.2 %	-7.23%
Biosimilars - Brenzys 1.2 %	75	1.2 %	73	1.2 %	-2.67%
Cardiovascular - Rosuzet 1.1 %	71	1.1 %	70	1.1 %	-1.41%
Biosimilars - Hadlima 0.7 %	19	0.3 %	44	0.7 %	+131.58%
Women's Health - Jada 0.7 %	-	-	43	0.7 %	-
Biosimilars - Aybintio 0.7 %	39	0.6 %	43	0.7 %	+10.26%

USD in Million	2022	Weight	2023	Weight	Delta
Europe and Canada 26.7 %	1,631	26.4 %	1,673	26.7 %	+2.58%
United States 23.6 %	1,437	23.3 %	1,478	23.6 %	+2.85%
Asia Pacific and Japan 18.0 %	1,143	18.5 %	1,129	18.0 %	-1.22%
Latin America, Middle East, Russia and Africa 15.4 %	895	14.5 %	965	15.4 %	+7.82%
China 13.8 %	917	14.9 %	864	13.8 %	-5.78%
Global 2.5 %	151	2.4 %	154	2.5 %	+1.99%

Managers	Title	Age	Since
Kevin Ali CEO	Chief Executive Officer	63	21-06-01
Matthew Walsh DFI	Director of Finance/CFO	57	21-06-01
Juan Camilo Arjona Ferreira CTO	Chief Tech/Sci/R&D Officer	54	23-09-04
Rachel Stahler CTO	Chief Tech/Sci/R&D Officer	48	20-12-31
Marcel van Duin CTO	Chief Tech/Sci/R&D Officer	-	22-10-31
Jennifer Halchak IRC	Investor Relations Contact	-	-
Charlotte Owens PRN	Corporate Officer/Principal	-	23-09-04
Kirke Weaver LAW	General Counsel	51	22-06-30
Vittorio Nisita PRN	Corporate Officer/Principal	56	21-06-01
Joseph Morrissey PRN	Corporate Officer/Principal	59	21-06-01

Members of the board	Title	Age	Since
Rochelle Lazarus BRD	Director/Board Member	76	21-06-01
Carrie Cox CHM	Chairman	66	21-06-01
Robert Essner BRD	Director/Board Member	76	21-06-01
Helene Gayle BRD	Director/Board Member	68	21-06-01
Shalini Sharp BRD	Director/Board Member	49	21-06-01
R. Alan B. Ezekowitz BRD	Director/Board Member	70	21-06-01
Philip Ozuah BRD	Director/Board Member	61	21-06-01
Grace Whiteford BRD	Director/Board Member	61	21-06-01
Ma. Fatima Francisco BRD	Director/Board Member	55	21-06-01
Kevin Ali CEO	Chief Executive Officer	63	21-06-01

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	257,170,727	256,767,006 ( 99.84 %)	0	99.84 %

Name	Equities	%	Valuation
BlackRock Advisors LLC 12.69 %	32,439,792	12.69 %	598 M $
Vanguard Fiduciary Trust Co. 12.04 %	30,789,850	12.04 %	567 M $
Massachusetts Financial Services Co. 3.972 %	10,152,847	3.972 %	187 M $
STATE STREET CORPORATION 3.636 %	9,295,345	3.636 %	171 M $
Citadel Securities GP LLC 2.416 %	6,177,010	2.416 %	114 M $
Slate Path Capital LP 2.013 %	5,145,786	2.013 %	95 M $
Eaton Vance Management 1.971 %	5,038,820	1.971 %	93 M $
Sound Shore Management, Inc. 1.966 %	5,024,748	1.966 %	93 M $
LSV Asset Management 1.756 %	4,488,828	1.756 %	83 M $
BNY Mellon Investment Adviser, Inc. 1.563 %	3,996,455	1.563 %	74 M $

Organon & Co.

30 Hudson Street 33rd floor

07302, Jersey City

+551 430 6900

http://www.organon.com

Name	Category and Sector
FULFORD (INDIA) LIMITED	Pharmaceuticals: Major
Organon (India) Pvt Ltd. Organon (India) Pvt Ltd. Pharmaceuticals: MajorHealth Technology Organon India Pvt Ltd. manufactures and distribution of pharmaceutical preparations. The company is headquartered in Mumbai, India.	Pharmaceuticals: Major
Dashtag Dashtag Financial ConglomeratesFinance Founded in 1906, Dashtag is a part of Organon & Co. and operates an investment holding British company. The company is based in Hoddesdon, UK.	Financial Conglomerates
GTS FI BV GTS FI BV Financial ConglomeratesFinance Part of Organon & Co., GTS FI BV is an investment holding Dutch company that provides financing services. The company is located in Netherlands.	Financial Conglomerates
Organon Finance 1 LLC	Finance/Rental/Leasing
Organon LLC
Organon Foreign Debt Co-Issuer BV Organon Foreign Debt Co-Issuer BV MiscellaneousMiscellaneous Part of Organon & Co., Organon Foreign Debt Co-Issuer BV is an investment holding and Dutch financing company. The company is located in the Netherlands.	Miscellaneous

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

21.33 USD

Average target price

22.5 USD

Spread / Average Target

+5.49%

Consensus

Estimates Revisions

Company calendar

	1st Jan change	Capi.
ORGANON & CO.	+47.92%	5.49B
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
NOVARTIS AG	+9.78%	210B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.17%	164B

Other Pharmaceuticals

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals